Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX).
Tane K, Shiono S, Wakabayashi M, Kataoka T, Mitome N, Fukuda H, Aokage K, Watanabe SI; In behalf of the Lung Cancer Surgical Study Group/Japan Clinical Oncology Group. Tane K, et al. Among authors: aokage k. Jpn J Clin Oncol. 2024 May 1:hyae056. doi: 10.1093/jjco/hyae056. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 38693750
Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non-small cell lung cancer.
Nagasaki Y, Taki T, Nomura K, Tane K, Miyoshi T, Samejima J, Aokage K, Ohtani-Kim SJ, Kojima M, Sakashita S, Sakamoto N, Ishikawa S, Suzuki K, Tsuboi M, Ishii G. Nagasaki Y, et al. Among authors: aokage k. J Natl Cancer Inst. 2024 Mar 8:djae053. doi: 10.1093/jnci/djae053. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 38459590
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
Hattori A, Suzuki K, Takamochi K, Wakabayashi M, Sekino Y, Tsutani Y, Nakajima R, Aokage K, Saji H, Tsuboi M, Okada M, Asamura H, Nakamura K, Fukuda H, Watanabe SI; Japan Clinical Oncology Group; West Japan Oncology Group. Hattori A, et al. Among authors: aokage k. Lancet Respir Med. 2024 Feb;12(2):105-116. doi: 10.1016/S2213-2600(23)00382-X. Epub 2024 Jan 3. Lancet Respir Med. 2024. PMID: 38184010 Clinical Trial.
Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.
Kitagawa S, Zenke Y, Taki T, Aokage K, Sakai T, Shibata Y, Izumi H, Nosaki K, Umemura S, Matsumoto S, Yoh K, Sakamoto N, Sakashita S, Kojima M, Tsuboi M, Goto K, Ishii G. Kitagawa S, et al. Among authors: aokage k. Lung Cancer. 2024 Feb;188:107453. doi: 10.1016/j.lungcan.2023.107453. Epub 2023 Dec 30. Lung Cancer. 2024. PMID: 38160515
Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L.
Maniwa T, Okami J, Miyoshi T, Wakabayashi M, Yoshioka H, Mimae T, Endo M, Hattori A, Nakagawa K, Isaka T, Isaka M, Kita R, Sekino Y, Mitome N, Aokage K, Saji H, Nakajima R, Okada M, Tsuboi M, Asamura H, Fukuda H, Watanabe SI; West Japan Oncology Group and Japan Clinical Oncology Group. Maniwa T, et al. Among authors: aokage k. J Thorac Cardiovasc Surg. 2023 Nov 23:S0022-5223(23)01099-1. doi: 10.1016/j.jtcvs.2023.11.023. Online ahead of print. J Thorac Cardiovasc Surg. 2023. PMID: 38000629
173 results